Wedbush Securities’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-176
Closed -$290K 984
2019
Q2
$290K Sell
176
-60
-25% -$104K 0.03% 643
2019
Q1
$480K Buy
236
+62
+36% +$109K 0.05% 418
2018
Q4
$223K Buy
174
+23
+15% +$35.3K 0.03% 644
2018
Q3
$285K Sell
151
-4
-3% -$8.26K 0.03% 600
2018
Q2
$315K Sell
155
-23
-13% -$52.4K 0.04% 535
2018
Q1
$393K Sell
178
-73
-29% -$186K 0.05% 434
2017
Q4
$579K Sell
251
-23
-8% -$46.7K 0.07% 331
2017
Q3
$488K Sell
274
-33
-11% -$46.1K 0.06% 403
2017
Q2
$418K Sell
307
-21
-6% -$25.3K 0.05% 433
2017
Q1
$386K Sell
328
-54
-14% -$55.1K 0.05% 433
2016
Q4
$305K Buy
382
+11
+3% +$8.73K 0.04% 494
2016
Q3
$325K Sell
371
-11
-3% -$7.97K 0.05% 475
2016
Q2
$214K Sell
382
-4
-1% -$2.27K 0.04% 600
2016
Q1
$213K Buy
386
+19
+5% +$11.7K 0.04% 567
2015
Q4
$305K Buy
367
+23
+7% +$23K 0.06% 399
2015
Q3
$381K Buy
344
+36
+12% +$65.6K 0.08% 291
2015
Q2
$671K Sell
308
-66
-18% -$134K 0.12% 201
2015
Q1
$586K Sell
374
-29
-7% -$38.3K 0.1% 231
2014
Q4
$479K Buy
+403
New +$269K 0.07% 276
2014
Q3
Sell
-490
Closed -$245K 697
2014
Q2
$245K Buy
+490
New +$157K 0.04% 470

Other funds holding BLUE

Wedbush Securities's BLUE Position: Q3 2019 in Review

Wedbush Securities sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 176 shares — an estimated $290K sold.

Wedbush Securities first reported a position in BLUE in Q2 2014 and held it in 20 quarters. The position peaked at $671K in Q2 2015. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Wedbush Securities reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Wedbush Securities sold 176 bluebird bio shares in Q3 2019, an estimated $290K.
  • Wedbush Securities first reported a position in bluebird bio in Q2 2014 and held it in 20 quarters.
  • Wedbush Securities's bluebird bio position peaked at $671K in Q2 2015.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Wedbush Securities's 13F filing for Q3 2019, filed 17 Oct 2019.